C. Nocent

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Lung function parameters in omalizumab responder patients: An interesting tool?

Fabrice Paganin, G. Mangiapan, A. Proust et al. · Allergy · 2017 · 36 citations

Health Professions, Immunology, Pharmacotherapy +17

[Validation of an asthma knowledge questionnaire].

L. Nguyen, Chantal Rahérison, M Lheureux et al. · PubMed · 2003 · 11 citations

Medicine, Health Education, Internal Medicine +6

Unexpected Effects of Inhaled Fluticasone in an HIV Patient with Asthma

C. Nocent, Chantal Rahérison, M. Dupon et al. · Journal of Asthma · 2004 · 10 citations

Pharmacy, Internal Medicine, Pharmacotherapy +17

Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study

Thibault Payen, Jean Trédaniel, L. Moreau et al. · Respiratory Medicine and Research · 2020 · 10 citations

Medicine, Oncology, Pharmacology +15